欧洲动脉粥样硬化性心血管疾病危险因素控制不足：EUROASPIRE研究再次表明此情况 - Suppr

Suppr

超能文献

Inadequate control of atherosclerotic cardiovascular disease risk factors in Europe: EUROASPIRE repeats itself.

作者信息

Santos Raul D

机构信息

1 Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Brazil.

2 Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

出版信息

Eur J Prev Cardiol. 2019 May;26(8):820-823. doi: 10.1177/2047487319831476. Epub 2019 Feb 20.

DOI:10.1177/2047487319831476

PMID:30782013

Abstract

摘要

相似文献

Inadequate control of atherosclerotic cardiovascular disease risk factors in Europe: EUROASPIRE repeats itself.欧洲动脉粥样硬化性心血管疾病危险因素控制不足：EUROASPIRE研究再次表明此情况

Eur J Prev Cardiol. 2019 May;26(8):820-823. doi: 10.1177/2047487319831476. Epub 2019 Feb 20.

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.日常实践中的心血管疾病预防指南：八个欧洲国家的EUROASPIRE I、II和III调查比较

Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.

Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys.来自保加利亚、克罗地亚、波兰、罗马尼亚和英国的心血管高风险人群的生活方式及风险因素管理，这些人群参与了欧洲动脉粥样硬化预防调查（EUROASPIRE）III和IV初级保健调查。

Eur J Prev Cardiol. 2016 Oct;23(15):1618-27. doi: 10.1177/2047487316645474. Epub 2016 Apr 15.

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.心血管疾病高危人群的生活方式与风险因素管理。欧洲心脏病学会关于欧洲通过干预进行二级和一级预防以减少事件行动（EUROASPIRE）IV在14个欧洲地区开展的横断面调查的报告。

Eur J Prev Cardiol. 2016 Dec;23(18):2007-2018. doi: 10.1177/2047487316667784. Epub 2016 Sep 27.

Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.欧洲缺血性卒中后主要危险因素的控制：来自EUROASPIRE III调查中卒中特异性模块的数据。

Eur J Prev Cardiol. 2015 Oct;22(10):1354-62. doi: 10.1177/2047487314546825. Epub 2014 Aug 19.

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.欧洲冠心病患者生活方式、风险因素控制和循证药物使用的时间趋势：来自 3 项 EUROASPIRE 调查的结果，1999-2013 年。

Glob Heart. 2017 Dec;12(4):315-322.e3. doi: 10.1016/j.gheart.2015.11.003. Epub 2016 Mar 16.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.27 个国家的冠心病患者生活方式及对心血管危险因素控制的影响：欧洲心脏病学会 ESC-EORP EUROASPIRE V 注册研究结果。

Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.

Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.预防心血管疾病的综合风险管理：日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南——2012年执行摘要

J Atheroscler Thromb. 2013;20(7):603-15. doi: 10.5551/jat.15867. Epub 2013 Jul 25.

Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.治疗 A）生活方式改变：日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南（2012 版）执行摘要

J Atheroscler Thromb. 2013;20(12):835-49. doi: 10.5551/jat.18820. Epub 2013 Oct 29.

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.欧洲动脉粥样硬化调查III：对来自22个欧洲国家的冠心病患者的生活方式、风险因素及心脏保护药物治疗使用情况的调查。

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.

引用本文的文献

Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database.2型糖尿病患者的降脂治疗与低密度脂蛋白目标达成情况：来自意大利糖尿病专科医生协会数据库的趋势

Cardiovasc Diabetol. 2025 Feb 28;24(1):94. doi: 10.1186/s12933-025-02648-1.

Uncontrolled Cholesterol in Individuals with Severe Hypercholesterolemia in a Health Evaluation Program in Brazil.巴西健康评估项目中严重高胆固醇血症个体的胆固醇控制情况。

Arq Bras Cardiol. 2024 Nov 22;121(11):e20240116. doi: 10.36660/abc.20240116. eCollection 2024.

Do the Gender and the Number of Comorbidities and the Use of Tertiary Prevention Play a Role in the Severity of Anxiety and Depression in Patients with Coronary Artery Disease? A POLASPIRE II Study.性别、合并症数量及三级预防的使用在冠状动脉疾病患者焦虑和抑郁严重程度中起作用吗？一项POLASPIRE II研究。

J Clin Med. 2024 Jun 28;13(13):3812. doi: 10.3390/jcm13133812.

Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study.高强度他汀类药物治疗的心血管疾病高危患者低密度脂蛋白胆固醇目标的真实世界达成情况：TERESA研究

J Clin Med. 2023 Apr 28;12(9):3187. doi: 10.3390/jcm12093187.

Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.可预防的临床和心理社会因素可预测冠状动脉人群中三分之二的复发性心血管事件中的两起。

BMC Cardiovasc Disord. 2020 Feb 5;20(1):61. doi: 10.1186/s12872-020-01368-6.

The Future of Lipid-lowering Therapy.降脂治疗的未来。

J Clin Med. 2019 Jul 23;8(7):1085. doi: 10.3390/jcm8071085.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验